IPCA Laboratories Limited
Edelweiss Mutual Fund increased its stake in IPCA Laboratories Limited from 1.03% to 1.19%, raising its shareholding from 2,602,635 to 3,019,905 shares. This represents an increase of 417,270 shares.
A pharmaceutical manufacturer and marketer, Ipca Labs produces a wide range of medicines across therapeutic areas including antimalarials, anti-infectives, gastrointestinal treatments, and gynecological formulations. The company operates manufacturing facilities across India and exports its products to international markets. Its distinctive strength lies in its expertise in complex drug formulations, established distribution networks across Indian states, and a focus on affordable healthcare solutions for domestic and global markets.
AMC subsidiary of Edelweiss Financial Services. Manages over Rs 1.5 lakh crore across equity, debt, hybrid and alternative strategies. CEO Radhika Gupta is the most prominent woman leader in Indian asset management and has built a strong direct investor franchise through social media and investor education. Known for multi-asset and international fund-of-fund offerings.